Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Losartan Potassium NDC 68071-4891 by Nucare Pharmceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PDP - 68071 4891 9
NuCare Pharmaceuticals provides Losartan Potassium tablets in 25mg dosage. This oval-shaped, light green tablet is imprinted with "Moz PE" on one side and "45" on the other side. These are film-coated tablets and contain Losartan Potassium USP 25mg as the active ingredient. This medication is used to control high blood pressure and to prevent strokes if you have already had a stroke or a "mini-stroke" (transient ischemic attack). However, it is important to consult your doctor for medical advice about side effects before taking this medication. The product should be stored at controlled temperatures ranging between 59-86°F and should be kept away from the reach of children.*
Figure 1 - losartan fig1
This text is showing the percentage of patients with the primary endpoint for two medications, Atenolol and Losartan Potassium. It also mentions an adjusted risk reduction of 13% with a p-value of 0.021. The study was conducted for 66 months and there are time intervals mentioned as well.*
Figure 2 - losartan fig2
Figure 3 - losartan fig3
The text contains a table or graph labeled as "Figure 3", demonstrating Primary Endpoint Events within Demographic Subgroups. The table appears to show results for various subgroups such as age, gender, race, and history of VD. However, some of the text is not readable, making it difficult to provide a more detailed description.*
Figure-4 - losartan fig4
This seems to be the result of a clinical trial comparing the effect of Losartan Potassium and a Placebo on a certain group of patients. The trial showed that Losartan Potassium reduced the risk by 16.1% compared to the Placebo, with a statistical significance of p=0.022. However, without additional context or information, it is difficult to provide more details about the trial or its implications.*
Chemical Structure - losartan str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.